The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Your post says it all. "WE do not have the contacts, we do not have the information, we do not have the representation, we do not have the protection. We are exposed and at the mercy of others always. Its like you pay your money you take your chance. I invested in oil ended up in pharma and I do not know what has happened to the oil interests that were supposed to be so promising. My share investment days are coming to an end."
RBS is beginning to break out of a range. And its a basket case!
I'm wondering if the market size is so big why hasn't another pharma company invested in the secondary.Something does not add up here.
Anyone know the actual amount they have left as of the meeting yesterday.Thanks
Maybe I'm paranoid but I'm now thinking your an insider.You tend to show up when there is a press release.Your posting are of similar tone every time explaining the company line.You never dilvulge insider info. but you just post what's already in the public domain. I think i have you pegged (:
Multiple posting??So your paranoid as well! I just cannot see how you can say management have done a great job.The shares are trading below the reverse merger. Why? I want to know why if Episalvan has a potential €1.3 billion market and its main competitor has blown up why is the company trading at a 45 million market cap?Someone is lying! and thats not including Lujuxta revenues. I think that is a valid question and makes me question what the BOD are really doing!
Get off your high horse you pompous a $$ People are loosing real money here! I was a Fastnet Investor! I have sold some but i cant get rid of my shares the bid is so thin. I intend to hold my original 40000 shares that were converted from the fastnet era. I
What is going on? Is that tumbleweed I hear.
Im betting we will be well under .20 by then.
Not one person is talking about the dilution. Dilution is shareholder Cancer! Still while theres a pulse theres life
Massive mistake by management.
You said it man..management said they were not going to dilute shareholders and they lied thru their teeth.
And above the .24 price of the reverse merger.
Edwina do u know what dilution does to companies. Take a look a Providence Resourses. Guess what happens.. It leads to more dilution .. Im sure ex Fastnet shareholder are not too happy.
To dilute to 25% of the company after Rory Nealon telling me that he believed the market was significantly undervaluing the company very recently is a blatent lie. I'm thinking of reporting him! As a CFO he should not make those statements knowing the are raising money at a level much lower
Are you talking about Amicus's epidermolysis bullosa phase 3 trial failure as the company that has been set back?
Watson..if we have a dream team why are they selling shares at .20 when the reverse merger was at .24 over 1 1/2 years ago? Surely if our BOD Dream Team were so good the share price would be alot higher by now
When I talked to Rory Nealon he said to me he coukd understand why the share valuation was so low considering their phase 3 trial..So why dilute the company by 25%? Aim stock exchange Crooks! Will be selling all my shares in the next couple of days.
If they get their act together and start taxing these multi-national tax cheats David McWilliams says 'Ireland will be like Albania without the sun' Another headwind coming down the tracks..
https://www.linkedin.com/in/alan-harris-2b11935 Alot of work has gone into it but no upgrade since the merger with Amryt. Founder of Som Pharma.